Professor Garland obtained her Bachelor of Medicine at the University of Melbourne in 1971, and subsequently worked as a Research Fellow at Harvard University, Boston, USA. Suzanne commenced as Director of Clinical Microbiology at the Women’s in 1984.

Professor Garland is a regular advisor to the World Health Organisation on sexual and reproductive health infections, cervical cancer and human papillomavirus (HPV). Her laboratory is a Western Pacific WHO reference laboratory for HPV for the HPV Labnet.

Professor Garland has been a chief investigator for phase 3, clinical HPV vaccine trials for both the bivalent and quadrivalent vaccines and is currently measuring vaccine effectiveness post the vaccine rollout in Australia.